Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 15.131% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a) COc1ccccc1N1CCN(C(=O)c2ccc3[nH]c(C)c(C)c3c2)CC1
b) CC(O)CNc1ccc(-c2nn(C)c(=O)c3ccccc23)cc1[N+](=O)[O-]
c) O=C(CNC(=O)c1ccc2c(c1)OCCO2)N/N=C/c1ccco1
d) CCN(CC)C(=O)Cn1c(=O)n(-c2ccccc2)c(=O)c2c3c(sc21)CCC3
e) CCOc1ccc(C(=O)NN2C(=S)NC(C)(C)C=C2C)cc1
Answer: e. CCOc1ccc(C(=O)NN2C(=S)NC(C)(C)C=C2C)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOc1ccc(C(=O)NN2C(=S)NC(C)(C)C=C2C)cc1
CCOc1ccc(C(=O)NN2C(=S)NC(C)(C)C=C2C)cc1
4-ethoxy-N-(4,6,6-trimethyl-2-sulfanylidene-1H-pyrimidin-3-yl)benzamide